
Building Banani: How a Canvas-First AI Designer Is Raising the Floor on Product Design
Just Now PossibleShow Notes
What if the future of product design isn't about replacing designers — it's about giving every team access to one? For solo founders, stretched design teams, and early-stage startups, great UX has always been out of reach. Banani is trying to change that by building an AI product designer that doesn't just generate code — it generates design.
In this episode of _Just Now Possible_, Teresa Torres talks with Vlad Solomakha (CEO & Co-founder), Vova Parkhomchuk (CTO & Co-founder), and Vlad Ostapovats (Founding Growth) about how they built Banani from a Figma plugin proof-of-concept into a canvas-first AI design tool generating hundreds of thousands of designs per week. Vlad Solomakha brings a decade of design experience to the product — and a very specific vision of what it means for AI to produce beautiful, tasteful design rather than average, undifferentiated UI.
You'll hear how they engineered their agent to handle parallel screen edits, manage per-screen context across canvases with hundreds of frames, and make surgical edits without regenerating entire screens. They dig into the "gulf of specification" — the mismatch between how designers think visually and how agents understand text — and what they're building to close it.
It's a detailed look at what it takes to build an AI-native design tool that puts the designer in the driver's seat while letting the agent handle the production work.
More from Just Now Possible
What does it take to build an AI voice agent that people will talk to for 44 minutes about their own blind spots? Your360 AI found out, one call at a time.
What happens when you hand your opportunity solution tree to an AI? Vistaly rebuilt its entire product to find out—and the agents were the easy part.
What does it take to build an AI app builder specifically for product managers—not engineers—inside an already crowded market?
How do you build trustworthy AI diagnostic tools in one of medicine's most historically under-researched areas?
What does it take to reinvent a 14-year-old company—not once, but twice?